Researchers developed novel anti-cancer prostaglandins (PGs) with a cyclopentenone ring, showing potent tumor inhibition. PGJ2 derivatives demonstrated significant antitumor activity in vivo, comparable to cyclophosphamide, via alkylation mechanisms.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: